30 November 2021 in eLife
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that couples the binding of extracellular ligands, such as EGF and transforming growth factor-α (TGF-α), to the initiation of intracellular signaling pathways. EGFR binds to EGF and TGF-α with similar affinity, but generates different signals from these ligands. To address the mechanistic basis of this phenomenon, we have carried out cryo-EM analyses of human EGFR bound to EGF and TGF-α. We show that the extracellular module adopts an ensemble of dimeric conformations when bound to either EGF or TGF-α. The two extreme states of this ensemble represent distinct ligand-bound quaternary structures in which the membrane-proximal tips of the extracellular module are either juxtaposed or separated. EGF and TGF-α differ in their ability to maintain the conformation with the membrane-proximal tips of the extracellular module separated, and this conformation is stabilized preferentially by an oncogenic EGFR mutation. Close proximity of the transmembrane helices at the junction with the extracellular module has been associated previously with increased EGFR activity. Our results show how EGFR can couple the binding of different ligands to differential modulation of this proximity, thereby suggesting a molecular mechanism for the generation of ligand-sensitive differential outputs in this receptor family.
9 December 2020 in bioRxiv
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that couples the binding of extracellular ligands, such as EGF and transforming growth factor- α (TGF-α), to the initiation of intracellular signaling pathways. EGFR binds to EGF and TGF- α with similar affinity but generates different signals from these ligands. To address the mechanistic basis of this phenomenon, we have carried out cryo-EM analyses of human EGFR bound to EGF and TGF- α . We show that the extracellular module adopts an ensemble of dimeric conformations when bound to either EGF or TGF- α . The two extreme states of this ensemble represent distinct ligand-bound quaternary structures in which the membrane-proximal tips of the extracellular module are either juxtaposed or separated. EGF and TGF- α differ in their ability to maintain the conformation with the membrane-proximal tips of the extracellular module separated, and this conformation is stabilized preferentially by an oncogenic EGFR mutation. Close proximity of the transmembrane helices at the junction with the extracellular module has been associated previously with increased EGFR activity. Our results show how EGFR can couple the binding of different ligands to differential modulation of this proximity, thereby suggesting a molecular mechanism for the generation of ligand-sensitive differential outputs in this receptor family.
27 August 2026 in Philosophical Transactions of the Royal Society B: Biological Sciences
The human epidermal growth factor receptor (EGFR or HER1) and its three close relatives, HER2, HER3 and HER4, are receptor tyrosine kinases (RTKs) that regulate critical cellular processes and are frequently dysregulated in cancer. In contrast to RTKs that are activated primarily by trans-autophosphorylation, HER family receptors switch on through a fundamentally different mechanism based on asymmetric interactions between two kinase domains within a dimer. This distinctive mode of allosteric activation arose early in evolution and remains unique to the HER family. This review describes how ligand binding promotes asymmetric dimerization of the EGFR kinase domains, whereby one kinase (the ‘activator’) allosterically stabilizes the active conformation of its partner (the ‘receiver’) without requiring activation loop phosphorylation. Structural elements that enable this process include a hydrophobic activator/receiver interface, a membrane-proximal juxtamembrane ‘latch’ that stabilizes the dimer and an autoinhibitory element in the C-terminal tail that favours the inactive state. We discuss how oncogenic alterations, including the L858R mutation, exon 19 deletions and kinase domain duplications, drive ligand-independent asymmetric dimerization and how the action of the endogenous inhibitor MIG-6 and new allosteric inhibitors can be understood in the context of activator/receiver asymmetric dimerization. This article is part of the discussion meeting issue ‘Epidermal growth factor receptor after 40 years’.